Cipla infringing Roche's patent in lung cancer drug: HC
In a setback to Cipla, the Delhi High Court on Friday held that the Indian drug major was infringing Swiss pharmaceutical company Hoffman-La Roche`s patent in lung cancer drug erlotinib hydrochloride, sold under the name of Tarceva.
Nov 28, 2015, 00:11 AM IST